BlackRock Fund Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$202M Buy
7,867,804
+258,652
+3% +$6.8M 0.04% 641
2016
Q3
$208M Buy
7,609,152
+319,080
+4% +$8.76M 0.04% 515
2016
Q2
$206M Buy
7,290,072
+212,340
+3% +$5.46M 0.05% 486
2016
Q1
$167M Buy
7,077,732
+174,364
+3% +$3.84M 0.04% 579
2015
Q4
$155M Sell
6,903,368
-65,056
-0.9% -$1.48M 0.04% 632
2015
Q3
$161M Buy
6,968,424
+240,168
+4% +$6.02M 0.04% 569
2015
Q2
$166M Buy
6,728,256
+319,188
+5% +$7.97M 0.04% 603
2015
Q1
$161M Buy
6,409,068
+371,960
+6% +$8.84M 0.04% 632
2014
Q4
$139M Sell
6,037,108
-90,496
-1% -$2.07M 0.03% 682
2014
Q3
$143M Buy
6,127,604
+530,964
+9% +$12.4M 0.04% 588
2014
Q2
$130M Buy
5,596,640
+144,816
+3% +$3.2M 0.04% 682
2014
Q1
$116M Sell
5,451,824
-58,296
-1% -$1.31M 0.03% 734
2013
Q4
$130M Buy
5,510,120
+441,468
+9% +$9.57M 0.04% 645
2013
Q3
$101M Buy
5,068,652
+299,888
+6% +$5.69M 0.03% 736
2013
Q2
$82.4M Buy
+4,768,764
New +$79.2M 0.03% 803

Other funds holding TECH

BlackRock Fund Advisors's TECH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Bio-Techne (TECH) stake by 3.4% in Q4 2016, buying an estimated $6.8M and bringing the position to 7,867,804 shares worth $202M. The position accounts for 0.04% of the portfolio, ranked #641.

BlackRock Fund Advisors first reported a position in TECH in Q2 2013 and has held it in 15 quarters since. The position peaked at $208M in Q3 2016. 281 funds tracked by Wall St. Rank hold TECH as of Q4 2016.

  • BlackRock Fund Advisors held 7,867,804 shares of Bio-Techne worth $202M as of Q4 2016.
  • BlackRock Fund Advisors bought 258,652 Bio-Techne shares in Q4 2016, an estimated $6.8M.
  • Bio-Techne made up 0.04% of BlackRock Fund Advisors's portfolio in Q4 2016, its #641 holding.
  • BlackRock Fund Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Bio-Techne position peaked at $208M in Q3 2016.
  • 281 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.